Purpose. This study investigated the effect of expiratory muscle strength training (EMST) on voice production, dysarthria, and voice-related quality-of-life issues in persons with multiple sclerosis (PwMS). It was hypothesized that PwMS would have improved voice production and reduced voice-related quality-of-life issues following EMST. Participants and Methods. Seventeen participants with MS and 14 healthy (H) controls completed 8 weeks of EMST, followed by 4 weeks of no training. Analyzed outcomes as a function of EMST were maximal expiratory pressure (MEP), sustained vowel prolongation (SVP), words per minute (WPM) measured from connected speech, and quality-of-life indices related to the presence of the dysarthria and dysphonia. Results. PwMS had lower MEPs, shorter SVP, and less WPM than the controls prior to training. Following EMST, both groups had significant improvement in MEPs that stayed above baseline after training halted. EMST did not improve voice production or voice-related quality of life for PwMS. Conclusion. Respiratory muscle weakness is present in PwMS having mild- to moderate-level disability. EMST improved expiratory muscle strength but did not statistically change objective and subjective components of voice/speech production in PwMS.
Beukelman DR , Kraft GH, Freal J.Expressive communication disorders in persons with multiple sclerosis: a survey. Arch Phys Med Rehabil.1985;66(10):675-677.
4.
Darley FL, Brown JR, Goldstein NPDysarthria in multiple sclerosis. J Speech Hear Res. 1972;15(2):229-245.
5.
Gosselink R. , Kovacs L., Decramer M.Respiratory muscle involvement in multiple sclerosis. Eur Respir J.1999; 13(2): 449-454.
6.
Brück W.Inflammatory demyelination is not central to the pathogenesis of multiple sclerosis. J Neurol.2005;252(Suppl 5): v10-v15.
7.
Rovaris M., Gambini A., Gallo A., et al. Axonal injury in early multiple sclerosis is irreversible and independent of the short-term disease evolution. Neurology . 2005;65(10):1626-1630.
8.
Colton R., Hirano M.Understanding Voice Problems: A Physiological Perspective for Diagnosis and Treatment. Baltimore, MD: Williams & Wilkins; 1990.
9.
Hartman DENeurogenic dysphonia. Ann Otol Rhinol Laryngol.1984;93(1 Pt 1):57-64.
10.
Hixon T.Respiratory Function in Speech and Song. Boston, MA: College-Hill; 1987.
11.
Proctor D.Breathing, Speech, and Song. New York, NY: Springer-Verlag Wien; 1980.
12.
Romer LM, McConnell AKSpecificity and reversibility of inspiratory muscle training. Med Sci Sports Exerc.2003;35(2): 237-244.
13.
Wiens ME, Reimer MA, Guyn HLMusic therapy as a treatment method for improving respiratory muscle strength in patients with advanced multiple sclerosis: a pilot study. Rehabil Nurs.1999;24(2):74-80.
14.
Gosselink R. , Kovacs L., Ketelaer P., Carton H., Decramer M.Respiratory muscle weakness and respiratory muscle training in severely disabled multiple sclerosis patients. Arch Phys Med Rehabil.2000;81(6):747-751.
15.
Klefbeck B. , Hamrah Nedjad J.Effect of inspiratory muscle training in patients with multiple sclerosis. Arch Phys Med Rehabil.2003;84(7):994-999.
16.
Olgiati R., Girr A., Hugi L., Haegi V.Respiratory muscle training in multiple sclerosis: a pilot study. Schweiz Arch Neurol Psychiatr. 1989;140(1):46-50.
17.
Smeltzer SC , Lavietes MH, Cook SDExpiratory training in multiple sclerosis . Arch Phys Med Rehabil.1996;77(9):909-912.
18.
Hartelius L. , Buder EH, Strand EALong-term phonatory instability in individuals with multiple sclerosis. J Speech LangHear Res. 1997;40(5):1056-1072.
19.
Hartelius L. , Nord L., Buder EHAcoustic analysis of dysarthria associated with multiple sclerosis. Clin Linguistics Phonetics.1995;9(2):95-120.
20.
Hartelius L. , Runmarker B., Andersen O.Prevalence and characteristics of dysarthria in a multiple-sclerosis incidence cohort: relation to neurological data. Folia Phoniatr Logop.2000; 52(4):160-177.
21.
Hartelius L. , Runmarker B., Andersen O., Nord L.Temporal speech characteristics of individuals with multiple sclerosis and ataxic dysarthria: “scanning speech” revisited. Folia Phoniatr Logop.2000;52(5):228-238.
22.
Hartelius L. , Svensson P.Speech and swallowing symptoms associated with Parkinson's disease and multiple sclerosis: a survey. Folia Phoniatr Logop.1994; 46(1): 9-17.
23.
Espir ML, Watkins SM, Smith HVParoxysmal dysarthria and other transient neurological disturbances in disseminated sclerosis. J Neurol Neurosurg Psychiatry. 1966;29(4):323-330.
24.
Powers S., Howley. Exercise Physiology: Therory and Applications to Fitness and Performance . 6th ed. Boston, MA: McGraw Hill; 2005.
25.
Lamotte D., Thoumie P.[Multiple sclerosis and botulinum toxin]. Ann Readapt Med Phys.2003;46(6):299-302.
26.
Rontal E., Rontal M., Wald J., Rontal D.Botulinum toxin injection in the treatment of vocal fold paralysis associated with multiple sclerosis: a case report. J Voice.1999;13(2):274-279.
27.
Poser CM, Brinar VVDiagnostic criteria for multiple sclerosis. Clin Neurol Neurosurg.2001;103(1):1-11.
28.
Poser CM, Paty DW, Scheinberg L., et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol.1983;13(3):227-231.
29.
Kurtzke JFRating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology.1983; 33(11):1444-1452.
30.
Smeltzer SC , Lavietes MHReliability of maximal respiratory pressures in multiple sclerosis. Chest. 1999;115(6):1546-1552.
31.
Darley FL, Aronson A., Brown JRMotor Speech Disorder. Philadelphia, PA: W. B. Saunders; 1975.
32.
Hillel AD, Miller RM, Yorkston K., McDonald E., Norris FH, Konikow N.Amyotrophic lateral sclerosis severity scale. Neuroepidemiology . 1989;8(3):142-150.
33.
Yorkston KM, Mille RM, Strand EAHuntington's Management of Speech and Swallowing in Degenerative Diseases . Tucson, AZ: Communication Skill Builder; 1995.
34.
Yorkston KM , Strand E., Miller R., Hillel A., Smith K.Speech deterioration in amyotrophic lateral sclerosis: implications for the timing of intervention. J Med Speech-Language Pathol.1993; 1(1):35-46.
35.
Hogikyan ND , Sethuraman G.Validation of an instrument to measure voice-related quality of life (V-RQOL). J Voice.1999; 13(4):557-569.
36.
Hogikyan ND , Wodchis WP, Terrell JE, Bradford CR, Esclamado RMVoice-related quality of life (V-RQOL) following type I thyroplasty for unilateral vocal fold paralysis. J Voice.2000; 14(3):378-386.
37.
Black LF, Hyatt REMaximal respiratory pressures: normal values and relationship to age and sex . Am Rev Respir Dis.1969; 99(5):696-702.
38.
Black LF, Hyatt REMaximal static respiratory pressures in generalized neuromuscular disease . Am Rev Respir Dis.1971; 103(5):641-650.
39.
Laghi F., Tobin MJDisorders of the respiratory muscles. Am J Respir Crit Care Med.2003;168 (1):10-48.
40.
Gething AD, Williams M., Davies B.Inspiratory resistive loading improves cycling capacity: a placebo controlled trial. Br J Sports Med.2004;38(6):730-736.
41.
Sapienza CM , Davenport PW, Martin ADExpiratory muscle training increases pressure support in high school band students. J Voice.2002;16(4):495-501.
42.
Suzuki S., Sato M., Okubo T.Expiratory muscle training and sensation of respiratory effort during exercise in normal subjects. Thorax. 1995;50(4):366-370.
43.
Sharkey BJIntensity and duration of training and the development of cardiorespiratory endurance. Med Sci Sports. 1970;2(4):197-202.
44.
Sapir S., Pawlas A., Ramig L., Seeley E., Fox C., Corboy J.Effect of intensive phonatory-respiratory treatment (LSVT) on voice in two individuals with multiple sclerosis. J Med Speech-Language Pathol.2001; 9(2): 141-151.
45.
Cerny F., Panzarella K., Stathopoulus E.Expiratory muscles conditioning in hypotonic children with low vocal intensity levels. J Med Speech-Language Pathol.1997 ;5:141-152.
46.
Hoffman-Ruddy B.Expiratory Pressure Threshold Training in High-Risk Performers [Dissertation]. Gainesville, FL: Communication and Speech Disorders, University of Florida; 2001.
47.
Baker S.Expiratory Muscle Strength Training and Detraining: Effects on Speech and Cough Production [Dissertation]. Gainesville, FL: Communication and Speech Disorders, University of Florida; 2003.
48.
Chemo-Radiation Offers Better Post-Treatment Voice Quality for Laryngeal Cancer. Retrieved from http://www.innovations-report.com/html/reports/medicine_health/report-32208.html .
49.
University of Michigan Health System.Botox Injections Provide Long-Term Relief and Better Quality of Life for Voice Disorder Patients. Lasting Effects Seen in Three-Year Study of People With Spasmodic Dysphonia. Ann Arbor, MI: University of Michigan Health System. Retrieved from http://www.med.umich.edu/opm/newspage/2004/botox.htm.
